logo
IPO fundraising up 45% to Rs 45,350 cr in Jan-Jun despite global headwinds

IPO fundraising up 45% to Rs 45,350 cr in Jan-Jun despite global headwinds

Fundraising through initial public offerings (IPOs) rose to Rs 45,350 crore in the first half of 2025, marking a 45 per cent increase from a year ago, despite global trade headwinds, geopolitical conflicts, and macroeconomic concerns.
However, the number of IPOs declined to 24 during the period under review from 36 in the January-June period of 2024, indicating a rise in the average size of public issues.
Going forward, the IPO market is expected to remain cautiously optimistic in the second half of 2025, supported by robust inflows of domestic investment, positive investor sentiment, and strong growth visibility, experts said.
According to data shared by merchant bankers, 24 companies mobilised Rs 45,351 crore in the January-June period of 2025, compared to Rs 31,281 crore raised by 36 firms during the same period last year.
"The first half of the year saw market sentiment tempered by ongoing global trade tensions, geopolitical uncertainties, and macroeconomic challenges. Despite these concerns, companies successfully raised over Rs 45,000 crore via IPOs during this period," said Neha Agarwal, Managing Director and Head? Equity Capital Markets, JM Financial Institutional Securities.
Adding to the momentum, the first half of 2025 also witnessed a sharp rise in draft IPO filings with the Securities and Exchange Board of India (Sebi). A total of 118 companies submitted preliminary papers, up from 52 in the corresponding period of 2024.
JM Financial led the IPO league table, topping both volume and value charts with 10 issuances collectively raising Rs 26,838 crore in Q1FY26 alone, according to data from Prime Database.
During the January-June 2025 period, 24 mainboard IPOs were launched, with 67 per cent of them listing at a premium. The overall performance of IPOs remained strong, delivering an average return of around 25 per cent to investors.
Among the major IPOs launched during this period were HDB Financial Services (Rs 12,500 crore), Hexaware Technologies (Rs 8,750 crore), Schloss Bangalore (Rs 3,500 crore), and Ather Energy (Rs 2,981 crore).
Most of these IPOs consisted of a mix of fresh equity issuance and offer for sale by existing shareholders. The proceeds were primarily used to fund business expansion plans, repay debt, and meet working capital requirements.
A majority of the companies accessing the IPO route belonged to industrial sectors such as manufacturing and infrastructure, reflecting continued investor interest in core economy-driven businesses.
Further, in July, at least four IPOs have been launched and at least five are in the pipeline, indicating sustained market activity.
Looking ahead to the second half of 2025, the outlook remains cautiously optimistic, Ratiraj Tibrewal, CEO of Choice Capital Advisors, said.
He noted that economic conditions are expected to improve in H2 compared to H1, due to easing global and domestic headwinds such as inflation, interest rates, geopolitical tensions, and currency volatility.
Vinod Nair, Head of Research at Geojit Financial Services, added that this improvement could bode well for the stock market. However, he cautioned that premium valuations and a potential lack of foreign institutional and retail investor inflows could weigh on a year-on-year basis, considering the high base of Rs 1.3 trillion in H2CY24.
He further noted that earnings upgrades in Q1FY26 and Q2FY26, along with progress on a trade deal with the US, will play a key role in shaping the IPO market trend in the latter half of the year.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

India's Pharma Exports Have Shot Up By 92% In Last 6 Years: Minister
India's Pharma Exports Have Shot Up By 92% In Last 6 Years: Minister

India.com

time12 minutes ago

  • India.com

India's Pharma Exports Have Shot Up By 92% In Last 6 Years: Minister

New Delhi: Various schemes being implemented by the Centre to realise the vision of Aatmanirbhar Bharat in the pharmaceutical sector have resulted in India's exports of drugs and pharmaceuticals increasing by 92 per cent, from Rs 1,28,028 crore in FY2018-19 to Rs 2,45,962 crore in FY2024-25, the Parliament was informed on Friday. The schemes include the Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme, the Production Linked Incentive (PLI) Scheme for Pharmaceuticals, the PLI Scheme for Bulk Drugs, Scheme for Promotion of Bulk Drug Parks, and Strengthening of Pharmaceutical Industry scheme, Minister of State for Chemicals and Fertilisers Anupriya Patel told the Lok Sabha in a written reply to a question. The PRIP scheme has been launched with an outlay of Rs 5,000 crore to transform India's Pharma MedTech sector from cost- to innovation-based growth by strengthening research and promoting industry-academia linkage for research and development in priority areas in drug discovery and development and medical devices. Under this scheme, seven Centres of Excellence (CoEs) have been set up, she said. The PLI Scheme for Pharmaceuticals aims to enhance India's manufacturing capabilities by increasing investment and production in the sector and contributing to product diversification to high-value goods in the pharmaceutical sector. The minister said that the scheme has enabled enhanced investment and production in eligible products. As of March 2025, the committed investment of Rs 17,275 crore targeted over the six-year period of the scheme stands substantially exceeded with a cumulative investment of Rs 37,306 crore made by the scheme's third year, and cumulative sales of approved products of Rs 2,66,528 crore have been made, including exports of Rs 1,70,807 crore. The PLI Scheme for Bulk Drugs, which has a total budgetary outlay of Rs 6,940 crore, aims to avoid disruption in the supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs for which there are no alternatives by reducing supply disruption risk due to excessive dependence on a single source. As of March 2025, the committed investment of Rs 3,938.5 crore under projects approved under the scheme for investment over the six-year production period of the scheme stands substantially exceeded with a cumulative investment of Rs 4,570 crore made by the scheme's third year, she further stated. The minister also highlighted that the government launched the Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme to make quality generic medicines available at affordable prices to all. Under the scheme, dedicated outlets known as Jan Aushadhi Kendras (JAKs) are opened across the country to provide medicines at prices that are about 50 per cent to 80 per cent lower than those of leading branded medicines in the market. Till June 6, 2025, a total of 16,912 JAKs have been opened, and on average, about 10 to 12 lakh persons visit these Kendras daily and avail of quality medicines at affordable prices. As many as 2,110 medicines and 315 surgicals, medical consumables and devices are under the scheme product basket, covering all major therapeutic groups, such as cardiovascular, anti-cancer, anti-diabetic, anti-infectives, anti-allergic and gastro-intestinal medicines and nutraceuticals. As a result of the scheme, in the last 11 years, estimated savings of about Rs 38,000 crore have accrued to citizens in comparison to the prices of branded medicines. Further, the scheme has provided self-employment to over 16,000 persons, including over 6,800 women entrepreneurs, the minister added.

Hyundai India Gets Rs 517.34 Cr Tax With Penalty Demand From GST Authority, Here's Why
Hyundai India Gets Rs 517.34 Cr Tax With Penalty Demand From GST Authority, Here's Why

News18

time20 minutes ago

  • News18

Hyundai India Gets Rs 517.34 Cr Tax With Penalty Demand From GST Authority, Here's Why

Last Updated: The company said there is no impact on its financial, operational or other activities due to the order and is reviewing the order and will exercise the right to file an appeal. Hyundai Motor India Ltd on Tuesday said it has received a demand of Rs 517.34 crore from tax authorities, along with penalty, for alleged short payment of GST compensation cess on its certain SUV models. The company has received an order from Commissioner (Appeals), CGST Dept, Tamil Nadu, confirming GST compensation cess demand of Rs 258.67 crore, along with penalty of Rs 258.67 crore, on the allegation of short payment of GST compensation cess on certain SUV models for the period September 2017 – March 2020, Hyundai Motor India Ltd said in a regulatory filing. Reacting to the demand, a company spokesperson said, 'HMIL is of the view that the amendment and the clarifications given by the Central Board of Indirect Tax and Customs (CBIC) to resolve the issue faced by the industry on this matter are in favour of the company. We are in the process of reviewing the order and will exercise the right to seek a legal remedy through an appropriate forum." The company asserted that there is no impact on its financial, operational or other activities due to the order and is reviewing the order and will exercise the right to file an appeal. . view comments First Published: July 26, 2025, 08:17 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Atal Pension Yojana enrolments cross 8 crore mark; adds 39 lakh new subscribers so far in FY26
Atal Pension Yojana enrolments cross 8 crore mark; adds 39 lakh new subscribers so far in FY26

Time of India

time24 minutes ago

  • Time of India

Atal Pension Yojana enrolments cross 8 crore mark; adds 39 lakh new subscribers so far in FY26

Social Security scheme Atal Pension Yojana has crossed 8 crore total gross enrolments, with an addition of 39 lakh new subscribers so far in the current fiscal, the Finance Ministry said on Friday. APY was launched on May 9, 2015. Explore courses from Top Institutes in Please select course: Select a Course Category Technology others Digital Marketing MBA Operations Management Healthcare MCA healthcare Data Analytics Management Cybersecurity Finance Leadership Others Project Management PGDM Public Policy Data Science Artificial Intelligence CXO Design Thinking Product Management Degree Data Science Skills you'll gain: Duration: 12 Weeks MIT xPRO CERT-MIT XPRO Building AI Prod India Starts on undefined Get Details "The Atal Pension Yojana (APY), a flagship social security scheme of the Government of India administered by PFRDA , has achieved a significant milestone by surpassing 8 crore total gross enrolments with an addition of 39 lakh new subscribers in the current Financial Year (FY 2025-26) alone," the ministry said in a statement. Launched with a vision to create a universal social security system for all Indians, APY is a voluntary, contributory pension scheme , focused on the poor, the underprivileged, and workers in the unorganised sector. APY assures a guaranteed monthly pension of Rs 1,000 to Rs 5,000 for the subscriber post-60 years of age, the same pension to the spouse after the subscriber's demise, and return of the accumulated corpus to the nominee after the death of both. It is open to all Indian citizens between the age of 18-40 years, except those who are or have been income tax payers.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store